Valuing any early-stage company in an emerging industry is difficult – and that difficulty only intensifies in the nascent cannabis and hemp sectors. Some argue that any cannabis or hemp company valuation is a best-effort guess in a fast-changing landscape.

There is no better time for the new “BVR Briefing - Cannabis and Hemp Valuations: A Market Analysis” study by leading experts Ryan Cram, CVA, and Ron Seigneur, CPA/ABV, CVA, ASA.  Cram and Seigneur - who are gaining notoriety as the authoritative minds in cannabis and hemp valuation - present an empirically-based alternative to the “one-size-fits-all” application of market approach in the cannabis industry. Their expert analysis puts current cannabis market sentiment and factors in the context of privately-held growth assets and relies upon the same rigor in data selection and research. The two experts scrutinize the math behind the headline-grabbing deals and stock prices that have dominated news - and market expectations - around exit values and market multiples.